SMU1 Activators
SMU1 Activators are a distinct class of chemical compounds designed to enhance the functional activity of SMU1, a protein that plays a critical role in RNA splicing and the regulation of gene expression. These activators are specifically tailored to modulate the pathways that SMU1 is involved in, without altering its transcription or translation directly. The chemical activators of SMU1 work through various mechanisms to ensure that the protein's activity is upregulated at the post-translational level, focusing on the protein's native and specific signaling pathways. For instance, activators may stabilize SMU1 in its active conformation, increase its affinity for binding partners, or enhance its catalytic activity within the spliceosome complex. Some activators might bind to allosteric sites, causing conformational changes that promote SMU1's interaction with other splicing factors, thereby facilitating the assembly of the spliceosome and enhancing RNA splicing efficiency.
Furthermore, these SMU1 Activators can indirectly increase the activity of SMU1 by modulating the cellular environment in which SMU1 operates. Certain compounds might influence the phosphorylation state of SMU1 or its interacting partners, altering the dynamics of the splicing complex and the spliceosome assembly process. Others could act by affecting the levels of metal ions or cofactors that are essential for the catalytic activity of SMU1, thus indirectly contributing to its enhanced function. By precisely targeting the intricate network of interactions and processes that SMU1 is involved in, these activators ensure a more robust and efficient splicing mechanism, crucial for the correct processing of pre-mRNAs into mature mRNAs. The specificity of these compounds ensures that the activation of SMU1 is the main effect, rather than a broad impact on cellular pathways, making SMU1 Activators a focused tool for probing the function of SMU1 in cellular models.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels which in turn activate PKA. PKA can phosphorylate various proteins, potentially including SMU1, thereby enhancing its activity in cellular processes such as RNA splicing. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, enzymes that degrade cAMP and cGMP. By preventing cAMP degradation, IBMX can indirectly increase PKA activity, which may enhance SMU1's functionality in spliceosome assembly and regulation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits several protein kinases, potentially altering phosphorylation patterns in the cell. This can lead to changes in spliceosome dynamics and indirectly increase the activity of SMU1 within the RNA splicing machinery. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may phosphorylate substrates that interact with SMU1, modulating its role in pre-mRNA processing and alternative splicing events. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to its receptors, initiating a signaling cascade that can lead to the activation of MAPK/ERK pathway, potentially influencing the activity of SMU1 in RNA splicing. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
While staurosporine is a broad-spectrum kinase inhibitor, it can lead to a compensatory increase in specific kinases that may enhance the activation of SMU1 in its role within the spliceosome complex. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. By inhibiting PI3K, it may affect downstream signaling pathways such as Akt, potentially causing alterations in splicing factors and enhancing the activity of SMU1 in spliceosome assembly. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, which could activate calcium-dependent protein kinases. These kinases may phosphorylate regulatory proteins that interact with SMU1, enhancing its role in RNA splicing. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels. Elevated calcium can activate kinases that influence SMU1's activity in splicing regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is a histone deacetylase inhibitor, which can lead to a more relaxed chromatin state and potentially affect alternative splicing patterns. This chromatin remodeling may indirectly enhance SMU1’s function in spliceosome complex assembly. | ||||||